• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Acute toxicity outcomes and dosimetric implications from incidental irradiation of adjacent tissues in tangent field hypofractionated breast radiotherapy.切线野大分割乳腺放疗中相邻组织意外照射的急性毒性结果及剂量学影响
Rep Pract Oncol Radiother. 2020 May-Jun;25(3):345-350. doi: 10.1016/j.rpor.2020.02.009. Epub 2020 Feb 21.
2
Hypofractionated Whole-Breast Irradiation in Large-Breasted Women-Is There a Dosimetric Predictor for Acute Skin Toxicities?大乳房女性的部分乳房照射:急性皮肤毒性的剂量学预测因素?
Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):71-77. doi: 10.1016/j.ijrobp.2018.08.024. Epub 2018 Aug 24.
3
Bending moment of implants restored with CAD/CAM polymer-based restoration materials with or without a titanium base before and after artificial aging.使用基于CAD/CAM聚合物的修复材料修复的种植体在人工老化前后,有无钛基时的弯矩。
Dent Mater. 2022 Sep;38(9):e245-e255. doi: 10.1016/j.dental.2022.06.009. Epub 2022 Jun 15.
4
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra-target-tissue irradiation.一种针对大乳房和/或高体重指数患者的新型三维适形放射治疗(3DCRT)技术:旨在减少靶区外组织照射的新型射野评估方法的评估
Br J Radiol. 2016 Sep;89(1065):20160039. doi: 10.1259/bjr.20160039. Epub 2016 Jun 29.
5
Modifiable risk factors for acute skin toxicity in adjuvant breast radiotherapy: Dosimetric analysis and review of the literature.辅助性乳腺癌放疗中急性皮肤毒性的可改变风险因素:剂量学分析及文献综述
Med Dosim. 2019;44(1):51-55. doi: 10.1016/j.meddos.2018.01.004. Epub 2018 Mar 23.
6
Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.常规分割与低分割全乳放疗的急性和短期毒性效应:一项随机临床试验。
JAMA Oncol. 2015 Oct;1(7):931-41. doi: 10.1001/jamaoncol.2015.2666.
7
Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial.基于丹麦乳腺癌随机分组(DBCG)HYPO试验中治疗计划质量评估的全乳放疗剂量限制
Clin Transl Radiat Oncol. 2021 Apr 6;28:118-123. doi: 10.1016/j.ctro.2021.03.009. eCollection 2021 May.
8
Feasibility and acute toxicity of hypofractionated radiation in large-breasted patients.大乳房患者的少分次放射治疗的可行性和急性毒性。
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):79-83. doi: 10.1016/j.ijrobp.2011.05.074. Epub 2011 Oct 27.
9
Dosimetric comparison of partial and whole breast external beam irradiation in the treatment of early stage breast cancer.早期乳腺癌治疗中部分乳腺与全乳腺外照射的剂量学比较
Med Phys. 2007 Dec;34(12):4640-8. doi: 10.1118/1.2799579.
10
[Dosimetric comparison of external partial breast irradiation with whole breast irradiation and partial breast brachytherapy].[外照射部分乳腺放疗与全乳放疗及部分乳腺近距离放疗的剂量学比较]
Magy Onkol. 2014 Jun;58(2):108-15. Epub 2014 Feb 5.

本文引用的文献

1
Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer.乳腺癌 Hypofractionated 放射治疗的急性毒性和生活质量。
Int J Radiat Oncol Biol Phys. 2020 Aug 1;107(5):943-948. doi: 10.1016/j.ijrobp.2020.03.049. Epub 2020 Apr 22.
2
Predictors of radiation-induced acute skin toxicity in breast cancer at a single institution: Role of fractionation and treatment volume.单机构乳腺癌放疗所致急性皮肤毒性的预测因素:分割剂量和治疗体积的作用
Adv Radiat Oncol. 2017 Nov 6;3(1):8-15. doi: 10.1016/j.adro.2017.10.007. eCollection 2018 Jan-Mar.
3
Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.全乳放射治疗:美国放射肿瘤学会(ASTRO)基于证据的指南执行摘要。
Pract Radiat Oncol. 2018 May-Jun;8(3):145-152. doi: 10.1016/j.prro.2018.01.012. Epub 2018 Mar 12.
4
Characterization of risk factors for adjuvant radiotherapy-associated pain in a tri-racial/ethnic breast cancer population.三种族/族裔乳腺癌人群中辅助放疗相关疼痛的危险因素特征分析。
Pain. 2016 May;157(5):1122-1131. doi: 10.1097/j.pain.0000000000000489.
5
Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity.大分割乳腺放疗:疗程更短,毒性更低。
Clin Breast Cancer. 2016 Aug;16(4):262-8. doi: 10.1016/j.clbc.2015.09.012. Epub 2015 Sep 25.
6
Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.常规分割与低分割全乳放疗的急性和短期毒性效应:一项随机临床试验。
JAMA Oncol. 2015 Oct;1(7):931-41. doi: 10.1001/jamaoncol.2015.2666.
7
Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort.不同分割方案的乳腺癌放疗急性毒性效应差异:大型多中心队列中医生评估和患者报告结局的比较分析。
JAMA Oncol. 2015 Oct;1(7):918-30. doi: 10.1001/jamaoncol.2015.2590.
8
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.英国乳腺癌放射治疗标准化(START)试验——早期乳腺癌放射治疗的分割方案优化:两项随机对照临床试验的 10 年随访结果。
Lancet Oncol. 2013 Oct;14(11):1086-1094. doi: 10.1016/S1470-2045(13)70386-3. Epub 2013 Sep 19.
9
Long-term results of hypofractionated radiation therapy for breast cancer.乳腺癌分次照射的长期疗效。
N Engl J Med. 2010 Feb 11;362(6):513-20. doi: 10.1056/NEJMoa0906260.
10
Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial.局部肿瘤切除术后早期乳腺癌患者放疗分次剂量对肿瘤控制的影响:一项随机试验的长期结果
Lancet Oncol. 2006 Jun;7(6):467-71. doi: 10.1016/S1470-2045(06)70699-4.

切线野大分割乳腺放疗中相邻组织意外照射的急性毒性结果及剂量学影响

Acute toxicity outcomes and dosimetric implications from incidental irradiation of adjacent tissues in tangent field hypofractionated breast radiotherapy.

作者信息

Alcorn Sara R, Sloan Lindsey, McNutt Todd R, Stinson Susan F, Asrari Fariba, Croog Victoria J, Floreza Bethlehem, Weaver Arcelia, Wright Jean L

机构信息

Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.

出版信息

Rep Pract Oncol Radiother. 2020 May-Jun;25(3):345-350. doi: 10.1016/j.rpor.2020.02.009. Epub 2020 Feb 21.

DOI:10.1016/j.rpor.2020.02.009
PMID:32214909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7083790/
Abstract

PURPOSE

Adjacent tissues-in-beam (TIB) may receive substantial incidental doses within standard tangent fields during hypofractioned whole breast irradiation (HF-WBI). To characterize the impact of dose to TIB, we analyzed dosimetric parameters of TIB and associated acute toxicity.

MATERIALS AND METHODS

Plans prescribed to 40.5 Gy/15 fractions from 4/2016-1/2018 were evaluated. Structures of interest were contoured: (1) TIB: all tissues encompassed by plan 30% isodose lines, (2) breast, (3) non-breast TIB (nTIB): TIB minus contoured breast. Volumes of TIB, breast, and nTIB receiving 100%-107% of prescription dose (V100-V107) were calculated. Twelve patient- and physician-reported acute toxicities were prospectively collected weekly. Correlations between volumetric and dosimetric parameters were assessed. Uni- and multivariable logistic regressions evaluated toxicity grade changes as a function of TIB, breast, and nTIB V100-V107 (in cm).

RESULTS

We evaluated 137 plans. Breast volume was positively correlated with nTIB and nTIB V100 (rho = 0.52, rho = 0.30, respectively, both p < 0.001). V107 > 2 cm were noted in 14% of breast and 21% of nTIB volumes. On multivariable analyses, increasing breast and nTIB V100 significantly raised odds of grade 2+ dermatitis and burning/twinging pain, respectively; increasing nTIB V105 elevated odds of hyperpigmentation and burning pain; and increasing nTIB V107 raised odds of burning pain. Threshold volumes for >6-fold odds of developing burning pain were TIB V105 > 100 cm and V107 > 5 cm.

CONCLUSIONS

For HF-WBI, doses to nTIB over the prescription predicted acute toxicities independent of breast doses. These data support inclusion of TIB as a region of interest in treatment planning and protocol design.

摘要

目的

在大分割全乳照射(HF-WBI)期间,射野内相邻组织(TIB)在标准切线野中可能会接受大量的附带剂量。为了描述TIB剂量的影响,我们分析了TIB的剂量学参数及相关急性毒性。

材料与方法

评估2016年4月至2018年1月期间处方剂量为40.5Gy分15次照射的计划。勾勒出感兴趣的结构:(1)TIB:计划30%等剂量线所包含的所有组织;(2)乳腺;(3)非乳腺TIB(nTIB):TIB减去勾勒出的乳腺。计算接受处方剂量100%-107%(V100-V107)的TIB、乳腺和nTIB的体积。前瞻性地每周收集12项患者和医生报告的急性毒性反应。评估体积参数和剂量学参数之间的相关性。单变量和多变量逻辑回归评估毒性分级变化与TIB、乳腺和nTIB的V100-V107(单位:cm)的函数关系。

结果

我们评估了137个计划。乳腺体积与nTIB和nTIB的V100呈正相关(相关系数分别为0.52和0.30,均p<0.001)。14%的乳腺体积和21%的nTIB体积中观察到V107>2cm。在多变量分析中,乳腺和nTIB的V100增加分别显著增加2级及以上皮炎和灼痛/刺痛的几率;nTIB的V105增加会增加色素沉着和灼痛的几率;nTIB的V107增加会增加灼痛的几率。发生灼痛几率增加6倍以上的阈值体积为TIB的V105>100cm和V107>5cm。

结论

对于HF-WBI,超过处方剂量的nTIB剂量可预测独立于乳腺剂量的急性毒性。这些数据支持将TIB纳入治疗计划和方案设计中的感兴趣区域。